ArticleCancer immunology, immunotherapy : CII2014

The anti-lymphoma activities of anti-CD137 monoclonal antibodies are enhanced in FcγRIII(-/-) mice.

Michelle A Sallin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.